Myriad Genetics, Inc.MYGNNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+7.7%
5Y CAGR+5.7%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+7.7%/yr
vs -0.1%/yr prior
5Y CAGR
+5.7%/yr
Consistent
Acceleration
+7.9pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$106.80M-5.8%
2024$113.40M+27.8%
2023$88.70M+3.9%
2022$85.40M+4.3%
2021$81.90M+1.2%
2020$80.90M+4.8%
2019$77.20M-10.1%
2018$85.90M+21.3%
2017$70.80M-4.8%
2016$74.40M-